Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|
| Dir | | 474.0K | $234.23M | -18,410 |
| Dir | Taub Rebecca | 455.8K | $225.25M | -240 |
| Dir | | 357.8K | $176.82M | - |
| Dir | | 211.7K | $104.61M | -24,800 |
| Dir | | 201.3K | $99.46M | - |
Transactions
50 transactions · page 10
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|
| 2023-12-13 | BAKER BROS. ADVISORS LP | Director | Buy | 26,203 | $222.52 | $5,830,675.75 | +0.3% | → |
| 2023-12-13 | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | Sale+OE | 3,800 | $222.82 | $846,700.00 | -13.4% | → |
| 2023-12-12 | BAKER BROS. ADVISORS LP | Director | Buy | 34,578 | $218.31 | $7,548,615.76 | +0.1% | → |
| 2023-12-05 | Lynch Brian Joseph | SVP and General Counsel | Sale+OE | 2,800 | $221.89 | $621,294.00 | -5.7% | → |
| 2023-11-30 | Lynch Brian Joseph | SVP and General Counsel | Sale+OE | 3,000 | $204.58 | $613,730.00 | -5.9% | → |